Showing all results Page 1 of 5

Point-of-care testing hub

Clearstate offers market data, forecasts, and trend predictions to give you the insight to adjust your business strategy to the increasing demand for affordable POC tests. Find out more on the point-of-care testing hub.

  • Page
  • Healthcare
  • Global
  • EIU Healthcare
  • Point-of-care testing (POCT)

Global surgical device market

November 29th, 2021

Based on forecasts from Economist Intelligence Clearstate’s Surgical
Gateway and an additional survey of 20 global surgical device company
executives, this report aims to identify fast-growing opportunities for
businesses in the near future.

  • Campaign
  • Healthcare
  • Global

APAC IVD companies to watch in the infectious diseases diagnostics market

November 16th, 2021

Competition in Asia-Pacific’s infectious diseases diagnostics market is getting tougher. Homegrown firms from the region are ramping up their portfolio in infectious disease diagnostics and have emerged as the biggest competitive threat in the region.

  • Clearstate Insights
  • Healthcare
  • Asia
  • IVD Gateway

Covid-19: point-of-care vs. lab-based testing

November 16th, 2021

Covid-19 testing has emerged as a top priority for clinical laboratories and many IVD players. SARS-CoV-2 tests make up more than half of Asia-Pacific’s total infectious disease diagnostics market.

  • Clearstate Insights
  • Healthcare
  • Asia
  • EIU Healthcare
  • IVD Gateway
  • Molecular Diagnostics (MDx)
  • Point-of-care testing (POCT)

Infectious disease IVD testing: Where APAC countries are putting their attention

November 16th, 2021

Economist Intelligence Clearstate expects strong growth for Asia Pacific’s (APAC’s) infectious disease IVD market. Read our recent article to find out more.

Countries in the region are increasing spending and broadening access to IVD testing to tackle infectious diseases and meet disease elimination and control goals.

  • Clearstate Insights
  • Healthcare
  • Asia
  • IVD Gateway

Digital pathology growth to outpace broader TDx market in several countries

November 16th, 2021

Laboratories that adopt digital pathology, support the delivery of faster and more accurate diagnosis for diseases such as cancer. Economist Intelligence Clearstate anticipates strong demand for digital pathology solutions, with markets, such as Asia-Pacific, growing by 9.2% annually on average, in the forecast period of 2019-2024.

  • Clearstate Insights
  • Healthcare
  • IVD Gateway
  • Tissue Diagnostics (TDx)

Cancer and tissue diagnostics market outlook

November 12th, 2021

Tissue diagnostics (TDx) play an important role in improving treatment and health outcomes for cancer patients. A global effort to tackle the disease amid a growing cancer burden and rapid advances in treatment, drives the increased demand for TDx solutions. Download our latest report to explore the global cancer TDx landscape.

  • Clearstate Insights
  • Healthcare
  • Americas
  • Asia
  • Europe
  • IVD Gateway
  • Tissue Diagnostics (TDx)